New York Rybelsus Stomach Paralysis Lawsuit (2024 Update)

Quick Summary

• If you’ve experienced severe stomach issues like paralysis after taking Rybelsus in New York, you may wonder if you have a case for a lawsuit.
• This article covers the latest updates on the New York Rybelsus stomach paralysis lawsuit, discusses eligibility factors, and outlines the necessary steps to pursue legal action. Learn the essential details to protect your rights and seek potential compensation.
• If you or someone you know has faced complications from Rybelsus, Schmidt & Clark, LLP, is here to assist. Renowned for representing plaintiffs, our mission is to ensure you receive the justice and compensation you deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by specializing in pharmaceutical litigation, particularly cases involving medications linked to severe gastrointestinal issues like stomach paralysis. Our team of experienced attorneys is dedicated to guiding you through the complexities of filing a lawsuit related to medications like Rybelsus.

Using our expertise, we can help by offering the following services:

• Free confidential case evaluations
• Seeking fair compensation for your injuries
• Fighting for your rights

Rybelsus Stomach Paralysis Lawsuit

The Rybelsus stomach paralysis lawsuit has seen notable developments recently. In June 2024, Judge Karen Marston was appointed to preside over the case following Judge Pratter’s passing. This change caused a brief delay in proceedings, but the lawsuit is now progressing.

A status conference was held to discuss the direction of the case and the potential for extensive document production.

Plaintiffs’ lawyers have been working together, proposing a leadership slate of nearly two dozen attorneys to lead the case.

Additionally, a ‘Science Day’ was scheduled to provide the judge with non-binding technical information related to Rybelsus and other GLP-1 receptor agonists. These efforts aim to streamline the legal process and ensure that all technical aspects are thoroughly examined.

What is Rybelsus?

Rybelsus is specifically formulated for the treatment of type 2 diabetes. It is available by prescription and is one of the diabetes drugs that contains the active ingredient semaglutide. When used in conjunction with diet and exercise, semaglutide helps control blood sugar levels. The typical dosage for Rybelsus is 7 mg or 14 mg, taken once daily.

According to Healthline, Rybelsus, a weight loss drug, works by mimicking the GLP-1 hormone, which plays a crucial role in regulating blood sugar levels. Slowing digestion and making users feel full for longer periods helps curb food cravings and promote weight loss [1].

As one of the effective weight loss drugs, it has gained popularity among those seeking to manage their weight and blood sugar with the help of weight loss medication.

How Does Rybelsus Work?

Rybelsus works as a GLP-1 receptor agonist, containing semaglutide that mimics the hormone GLP-1 to regulate blood sugar levels. It stimulates the pancreas to release insulin and inhibits the release of glucagon, thereby stabilizing blood glucose levels.

Moreover, Rybelsus has the following effects on the body:

• Slows gastric emptying, which helps regulate the rate at which nutrients enter the bloodstream
• Binds to receptors in the brain, reducing appetite and increasing the feeling of fullness
• Prevents spikes in blood sugar levels

Rybelsus Side Effects and Symptoms

While Rybelsus is effective in controlling blood sugar levels, it has been linked to severe side effects, particularly concerning gastrointestinal health.

A study led by Jinmiao Lu highlighted the increased risk of stomach paralysis and other bowel injuries in diabetic patients taking GLP-1 receptor agonists like Rybelsus [2].

According to Jama, reports and clinical research have shown a connection between semaglutide drugs and severe stomach problems, including [3]:

• Stomach paralysis
• Bowel injuries
• Nausea
• Vomiting
• Diarrhea

If you are taking Rybelsus or any other GLP-1 receptor agonist and experience any of these symptoms, it is important to consult with your healthcare provider immediately.

The American College of Gastroenterology has also noted that medications like Ozempic and Mounjaro, which contain semaglutide, delay stomach emptying and may cause gastroparesis. These findings form the basis of many Rybelsus lawsuits, emphasizing the need for greater awareness and legal action.

Symptoms of stomach paralysis, or gastroparesis, from Rybelsus include:

• Chronic nausea
• Excessive Vomiting
• Bloating
• Stomach pain
• Abdominal Pain
• Malnutrition
• Early satiety (feeling full after eating only a small amount of food)
• Severe vomiting
• Changes in blood sugar levels

Complications can include severe dehydration, the formation of bezoars, and unpredictable blood sugar changes, significantly affecting the quality of life.

In addition to these, weight loss, decreased appetite, and acid reflux are frequently reported by patients suffering from gastroparesis. If you experience these symptoms while taking Rybelsus, it is crucial to seek medical advice promptly.

Rybelsus FDA-Approval and Its Black Box Warning

Rybelsus received FDA approval to treat type 2 diabetes, but it has since come under scrutiny for its potential side effects. In September 2023, the FDA issued a warning about semaglutide, the active ingredient in Rybelsus.

They stated that it has been reported to cause gastrointestinal disorders and bowel injuries. This warning is crucial for ongoing and future lawsuits as it highlights the recognized health risks associated with the drug.

In addition to this warning, the FDA has added a black box warning to the Ozempic label about the potential for increased risk of ileus. These enhanced warnings strengthen the plaintiffs’ arguments in the Ozempic lawsuit by demonstrating that the drug manufacturers were aware of the potential risks but did not adequately inform consumers.

Rybelsus carries a boxed warning about the risk of thyroid cancer. This is the most serious alert from the FDA – Ami Patel PharmD, BCPS, Pharmacist at UNC Health

How Do You Qualify for a Rybelsus Stomach Paralysis Lawsuit?

To qualify for a Rybelsus stomach paralysis lawsuit, you must show proof that you used the drug and suffered from serious side effects such as gastroparesis or stomach paralysis. Additionally, it would be best if you had a diagnosis from a healthcare professional linking your condition to Rybelsus.

Medical intervention, such as hospitalization due to the side effects, further strengthens your case. Individuals who used Rybelsus primarily for weight loss and experienced adverse health conditions may also qualify for a lawsuit. Collecting comprehensive medical records and evidence of the drug’s usage is crucial for building a strong case.

The Status Of The Rybelsus Stomach Paralysis Litigation in New York

The status of the Rybelsus stomach paralysis litigation in New York currently involves both class action and individual lawsuit options. Joining a class action lawsuit can provide collective strength, enabling individuals to pool their resources for a more robust case.

Class actions can expedite the legal process by consolidating numerous similar cases into one, reducing the burden on the court system.

However, class actions generally result in smaller individual settlements compared to what might be achieved in a successful individual lawsuit.

Individual lawsuits allow for personalized legal strategies tailored to specific circumstances, potentially leading to higher compensation but requiring more personal involvement and time.

Rybelsus Lawsuit Settlement Amounts in New York

Estimated settlement amounts for Rybelsus lawsuits in New York range between $400,000 and $700,000 for serious injuries.

Compensation types can include:

• Coverage for medical expenses.
• Payment for pain and suffering.
• Compensation for lost wages due to illness.

The amount of compensation varies greatly, reflecting the extent of losses and injury severity.

Securing compensation involves working towards a settlement out of court or presenting the case in a trial if necessary. Each case is unique, and the settlement amount will depend on the specific circumstances of the injury and the evidence presented.

Filing a Rybelsus Stomach Paralysis Lawsuit in New York

Filing a Rybelsus stomach paralysis lawsuit in New York begins with contacting experienced lawyers for a free case review to determine eligibility. Attorneys can navigate you through the legal process, ensuring all paperwork is completed before legal deadlines. Gathering evidence, such as medical records and testimonies, is crucial for building a strong case.

Hiring an attorney from the beginning ensures that you do not miss important paperwork or filing deadlines. Personal injury lawyers will track all important filing deadlines, making the process more manageable for you.

Legal Strategies and Challenges

One of the key legal strategies in Rybelsus lawsuits involves establishing causation through differential diagnosis rather than solely relying on gastric emptying studies. Plaintiffs argue that defendants understated the severity of conditions like ileus and bowel obstruction in their risk disclosures.

A significant challenge is the defendants’ attempt to limit the tests to prove causation to overly restrictive methods. Plaintiffs argue that these methods do not adequately consider individual patient histories or clinical judgments. Effective legal strategies need to address these challenges to build a compelling case.

Types of Evidence To Present

To build a strong case in a Rybelsus lawsuit, presenting the right types of evidence is crucial. You’ll need to provide proof that you were taking Rybelsus, Wegovy, or Ozempic, such as prescription records or pharmacy receipts.

Additionally, documentation from your healthcare providers that demonstrates you developed conditions like ileus, bezoars, intestinal blockages, gastroparesis, or stomach paralysis as a result of taking these medications is essential.

To build a strong case in your lawsuit, you will need to gather the following evidence:

• Medical records
• Diagnostic test results
• Medical bills
• Testimonies from medical experts who can link your condition to the use of Rybelsus

Collecting comprehensive and detailed evidence is key to achieving a favorable outcome in your lawsuit.

What Is the Statute of Limitations for a Rybelsus Lawsuit In New York?

The statute of limitations for a Rybelsus lawsuit in New York is three years from the date of injury. This means you must file your lawsuit within this period to be eligible for compensation. It’s crucial to consult with an attorney early to ensure you meet all state-specific deadlines and do not lose your right to seek damages.

For medical malpractice cases, the statute of limitations in New York is two years and six months, while wrongful death cases have a two-year limit. An attorney can help determine if any exceptions or exclusions to the statute of limitations apply to your case, ensuring you take timely and appropriate legal action.

Related Articles:

• Texas Rybelsus Stomach Paralysis Lawsuit
• Georgia Rybelsus Stomach Paralysis Lawsuit
• Michigan Rybelsus Stomach Paralysis Lawsuit

See all related dangerous drug lawsuits our attorneys covered so far.

Get Your Free Consultation From Our New York Rybelsus Lawyers

The Schmidt & Clark, LLP law firm stands ready to support you in difficult times. If you or a loved one has experienced complications from medications like Rybelsus, contact us.

Our seasoned team specializes in such cases and will navigate you through the legal process. We will clarify your rights and determine your eligibility for a lawsuit related to these complications.

Take advantage of our free case evaluation. Remember, we operate on a contingency fee basis—you pay only if we win your case. Trust that our dedication to your case is unwavering. We treat you with the same care as we would our own family. Contact us today for a thorough review of your situation.

Reference:

1. https://www.healthline.com/nutrition/how-to-get-rybelsus
2. https://www.researchgate.net/publication/368970811
3. https://jamanetwork.com/journals/jama/fullarticle/2810542